Elevated tumor necrosis factor-α and interleukin-6 in myocardium and serum of malfunctioning donor hearts

Circulation

Volumn 102, Issue 19, 2000, Pages

  Birks, Emma J ^a   Burton, Paul B J ^a   Owen, Virginia ^a   Mullen, Antony J ^a   Hunt, Diane ^a   Banner, Nicholas R ^a   Barton, Paul J R ^a   Yacoub, Magdi H ^a  

^a ROYAL BROMPTON AND HAREFIELD NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Molecular biology; Myocardium; Transplantation

Indexed keywords

INTERLEUKIN 6; MESSENGER RNA; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; CLINICAL ARTICLE; CYTOKINE RELEASE; FEMALE; HEART FAILURE; HEART MUSCLE; HEART TRANSPLANTATION; HEART VENTRICLE FUNCTION; HUMAN; IMMUNOASSAY; IMMUNOCYTOCHEMISTRY; MALE; ORGAN DONOR; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADULT; BIOLOGICAL MARKERS; BLOTTING, WESTERN; FEMALE; HEART; HEART TRANSPLANTATION; HUMANS; IMMUNOHISTOCHEMISTRY; INTERLEUKIN-6; MALE; MIDDLE AGED; MYOCARDIUM; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TISSUE DONORS; TUMOR NECROSIS FACTOR-ALPHA; VENTRICULAR DYSFUNCTION;

EID: 0034619546     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Preload-recruitable stroke work relationships and diastolic dysfunction in the brain -dead organ donor
2. Myocardial dysfunction in donor hearts: A possible etiology
3. The role of nitric oxide and cytokines in heart failure
4. Proinflammatory cytokine levels in patients with depressed left ventricular ejection fraction: A report from the studies of left ventricular dysfunction (SOLVD)
5. Haemodynamic, neuroendocrine and metabolic correlates of circulating cytokine concentrations in congestive heart failure
6. Tumor necrosis factor-α-converting enzyme and tumor necrosis factor-α in human dilated cardiomyopathy
7. Tumour necrosis factor and inducible nitric oxide synthase in dilated cardiomyopathy
8. Cellular basis for the negative inotropic effects of tumour necrosis factor-alpha in the adult mammalian heart
9. Pathophysiologically relevant concentrations of tumor necrosis factor-alpha promote left ventricular dysfunction and remodeling in rats
10. Interleukin-6 spillover in the peripheral circulation increases with the severity of heart failure, and the high plasma level of interleukin-6 is an important prognostic predictor in patients with congestive heart failure
11. Left-ventricular expression of interleukin-6 messenger-RNA higher in dilated than in ischaemic cardiomyopathy
12. Tumour necrosis factor gene and protein expression in adult feline myocardium after endotoxin administration
13. Effects of explosive brain death on cytokine activation of peripheral organs in the rat
14. Expression and functional significance of tumor necrosis factor receptors in human myocardium
15. Tumor necrosis factor soluble receptors in patients with various degrees of congestive heart failure
16. Soluble tumor necrosis factor binding proteins modulate the negative inotropic effects of TNF-α in vitro
17. Tumour necrosis factor-α up-regulates Gi alpha and G beta proteins and adenyl cyclase responsiveness in rat cardiomyocytes
18. Sphingosine mediates the immediate negative inotropic effects of tumour necrosis factor-α in the adult mammalian cardiac myocyte
19. Tumour necrosis factor alpha-induced apoptosis in cardiac myocytes: Involvement of the sphingolipid signalling cascade in cardiac cell death
20. Activation of the apoptotic pathway in dysfunctional donor hearts
21. Activation of matrix metalloproteinases in the failing human heart: Breaking the tie that binds
22. Interleukin-6 as a mediator of stunned myocardium
23. Continuous activation of gp130, a signal-transducing receptor component for interleukin 6-related cytokines, causes myocardial hypertrophy in mice
24. Hypoxic stress induces cardiac myocyte-derived interleukin-6
25. Safety and efficacy of a soluble P75 tumor necrosis factor receptor (Enbrel, Etanercept) in patients with advanced heart failure
26. Randomised investigation of effects of pentoxifylline on left-ventricular performance in idiopathic dilated cardiomyopathy